MHRA’s CEU seized quantity of suspected unlicensed medical products in Bolton


Share post:

The Medicines and Healthcare products Regulatory Agency’s (MHRA) Criminal Enforcement Unit (CEU) has seized a quantity of suspected unlicensed medical products including unlicensed versions of Botox, numbing agents and dermal fillers in Bolton, Greater Manchester.

Officers from the MHRA and Greater Manchester Police conducted a raid across nine addresses in Bolton, Westhoughton and Leigh in the early hours of Thursday 13 July 2023, where two women and a man were arrested.

Andy Morling, MHRA Deputy Director of Criminal Enforcement said: “Medicines like these are powerful and dangerous in the wrong hands, potentially leading to serious adverse health consequences. The criminals trading in these products are not only breaking the law, they also have no regard for your safety.

It is illegal to advertise, sell or supply medicines such as these without the appropriate authorisation. If you see these products, or any other powerful medicines, being sold on social media or elsewhere online, think. It’s unlikely to be legitimate. You can help the MHRA take action by reporting concerns to us through our Yellow Card scheme.

Our Criminal Enforcement Unit will continue working to protect your health by disrupting this harmful and illegal trade. We’re grateful to our partners in Greater Manchester Police, for helping in our efforts to do this today.

Detective Inspector James Coles from GMP’s Economic Crime Unit said: “This morning’s action showcases a really good example of partners working together to combat issues that are prevalent in our communities, we are determined to tackle money laundering in Greater Manchester and endeavour to make it as hard as possible for individuals to conceal illicit finance.

Whilst we have 3 in custody, an investigation remains ongoing, and we will continue to investigate and eradicate this type of criminal activity from the area.”



Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...